Yanheng Wu

864 total citations
16 papers, 523 citations indexed

About

Yanheng Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yanheng Wu has authored 16 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Yanheng Wu's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and RNA Interference and Gene Delivery (4 papers). Yanheng Wu is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and RNA Interference and Gene Delivery (4 papers). Yanheng Wu collaborates with scholars based in China, Australia and United States. Yanheng Wu's co-authors include Wenyi Gu, Zhi Ping Xu, Chen Chen, Ying Tang, Jiang Li, Xiaohui Zhao, Bing Sun, Guangyu Chen, Fatemeh Movahedi and Pei Cao and has published in prestigious journals such as ACS Applied Materials & Interfaces, Carcinogenesis and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Yanheng Wu

16 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanheng Wu China	14	233	206	169	106	68	16	523
Alicia Del Toro‐Arreola Mexico	12	134 0.6×	159 0.8×	296 1.8×	71 0.7×	54 0.8×	22	617
Ahad Khalilnezhad Iran	12	289 1.2×	177 0.9×	267 1.6×	50 0.5×	58 0.9×	17	583
Yihang Gong China	11	179 0.8×	131 0.6×	130 0.8×	71 0.7×	123 1.8×	23	461
Haoze Li China	12	200 0.9×	198 1.0×	134 0.8×	101 1.0×	72 1.1×	30	506
Xianguo Wu China	11	351 1.5×	150 0.7×	154 0.9×	57 0.5×	187 2.8×	18	689
Qingsi Wu China	13	192 0.8×	90 0.4×	192 1.1×	85 0.8×	49 0.7×	18	602
Alessia Zorzoli Italy	14	195 0.8×	309 1.5×	401 2.4×	33 0.3×	49 0.7×	26	764
Chupeng Hu China	9	195 0.8×	172 0.8×	180 1.1×	46 0.4×	54 0.8×	15	473
Israel Cañadas United States	9	389 1.7×	159 0.8×	201 1.2×	109 1.0×	209 3.1×	16	722

Countries citing papers authored by Yanheng Wu

Since Specialization

Citations

This map shows the geographic impact of Yanheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanheng Wu more than expected).

Fields of papers citing papers by Yanheng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanheng Wu. The network helps show where Yanheng Wu may publish in the future.

Co-authorship network of co-authors of Yanheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanheng Wu. A scholar is included among the top collaborators of Yanheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanheng Wu. Yanheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yan, Qi, Hong Zou, Xiaohui Zhao, et al.. (2022). Inhibition of colon cancer K-RasG13D mutation reduces cancer cell proliferation but promotes stemness and inflammation via RAS/ERK pathway. Frontiers in Pharmacology. 13. 996053–996053. 5 indexed citations

Xu, Jianliang, Zengjie Ye, Shutang Wang, et al.. (2022). Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin. BMC Cancer. 22(1). 671–671. 32 indexed citations

Sun, Bing, Xiaohui Zhao, Pei Cao, et al.. (2021). ATP stabilised and sensitised calcium phosphate nanoparticles as effective adjuvants for a DNA vaccine against cancer. Journal of Materials Chemistry B. 9(36). 7435–7446. 18 indexed citations

Tang, Ying, et al.. (2021). Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives. Molecular Therapy — Oncolytics. 22. 410–430. 48 indexed citations

Sun, Bing, Xiaohui Zhao, Yanheng Wu, et al.. (2021). Mannose-Functionalized Biodegradable Nanoparticles Efficiently Deliver DNA Vaccine and Promote Anti-tumor Immunity. ACS Applied Materials & Interfaces. 13(12). 14015–14027. 53 indexed citations

Sun, Bing, et al.. (2020). Bisphosphonate Stabilized Calcium Phosphate Nanoparticles for Effective Delivery of Plasmid DNA to Macrophages. ACS Applied Bio Materials. 3(2). 986–996. 19 indexed citations

Wu, Yanheng, Wenyi Gu, Li Li, Chen Chen, & Zhi Ping Xu. (2019). Enhancing PD-1 Gene Silence in T Lymphocytes by Comparing the Delivery Performance of Two Inorganic Nanoparticle Platforms. Nanomaterials. 9(2). 159–159. 38 indexed citations

Chen, Mingshui, Aditi Sharma, Yanling Lin, et al.. (2019). Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells. BMC Cancer. 19(1). 153–153. 38 indexed citations

Wu, Yanheng, Wenyi Gu, Jiang Li, Chen Chen, & Zhi Ping Xu. (2019). Silencing PD-1 and PD-L1 with Nanoparticle-Delivered Small Interfering RNA Increases Cytotoxicity of Tumor-Infiltrating Lymphocytes. Nanomedicine. 14(8). 955–967. 65 indexed citations

10.

Wu, Yanheng, et al.. (2018). Optimization of Formulations Consisting of Layered Double Hydroxide Nanoparticles and Small Interfering RNA for Efficient Knockdown of the Target Gene. ACS Omega. 3(5). 4871–4877. 18 indexed citations

11.

Wu, Yanheng, et al.. (2018). The molecular characteristics of avian influenza viruses (H9N2) derived from air samples in live poultry markets. Infection Genetics and Evolution. 60. 191–196. 21 indexed citations

12.

Gu, Wenyi, Lihui Wang, Yanheng Wu, & Junping Liu. (2018). Undo the brake of tumour immune tolerance with antibodies, peptide mimetics and small molecule compounds targeting PD‐1/PD‐L1 checkpoint at different locations for acceleration of cytotoxic immunity to cancer cells. Clinical and Experimental Pharmacology and Physiology. 46(2). 105–115. 17 indexed citations

13.

Hu, Lijuan, Yanheng Wu, Bo Zhao, et al.. (2016). Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing. Frontiers of Medicine. 10(1). 61–75. 43 indexed citations

14.

Liu, Hongbo, et al.. (2014). Effects of Different Lysis Buffers of Nucleic Acid Purification Kit on the Stability of Influenza Virus RNA. Future Virology. 9(6). 549–555. 3 indexed citations

15.

Yu, Chunping, Zhiling Zhang, Wenting Liao, et al.. (2012). The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway. Carcinogenesis. 33(3). 678–686. 39 indexed citations

16.

Yu, Weihua, Fugui Li, Xiaoyong Chen, et al.. (2011). PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells. The International Journal of Biochemistry & Cell Biology. 44(2). 377–384. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact